Mosseri Marlio Charles
Known title: 10% OwnerCIK: 0001806384
Mosseri Marlio Charles's purchase track record
How the stock did after each of Mosseri Marlio Charles's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
10
of 11 since June 15, 2023
Stock higher 6 months later
20%
3 months: 36%
Median 6-month return
-39.8%
3 months: -23.0%
Beat the S&P 500
20%
median -52.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/30/2026 | NVCT | $916K | +11.6% | pending | — |
| 10/23/2025 | NVCT | $957K | +45.8% | +46.3% | +5.5% |
| 6/17/2025 | NVCT | $314K | -23.4% | -5.2% | +13.7% |
| 5/6/2025 | NVCT | $407K | -23.0% | -34.4% | +20.8% |
| 2/7/2025 | NVCT | $1.20M | +34.0% | -10.6% | +6.0% |
| 12/13/2024 | NVCT | $80K | +88.3% | +78.9% | -1.2% |
| 7/26/2023 | NVCT | $209K | -35.4% | -45.2% | +6.6% |
| 7/18/2023 | NVCT | $374K | -35.3% | -49.7% | +4.6% |
| 7/5/2023 | NVCT | $405K | -30.4% | -47.6% | +5.8% |
| 6/23/2023 | NVCT | $1.55M | -17.8% | -51.0% | +9.3% |
| 6/15/2023 | NVCT | $1.03M | -23.0% | -53.1% | +6.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NVCT | ▲ Buy | Open Market | 50,000 | $916K | 6/30/2026 | View on chart |
| NVCT | ▲ Buy | Open Market | 72,836 | $457K | 10/27/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 35,034 | $215K | 10/24/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 46,900 | $284K | 10/23/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 5,603 | $45K | 6/20/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 28,043 | $226K | 6/18/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 5,399 | $44K | 6/17/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 21,167 | $172K | 5/12/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 50 | $433 | 5/8/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 100 | $865 | 5/8/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 100 | $865 | 5/8/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 2,400 | $21K | 5/8/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 2,703 | $23K | 5/7/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 9,614 | $83K | 5/7/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 2,340 | $20K | 5/6/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 10,104 | $87K | 5/6/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 240,000 | $1.2M | 2/7/2025 | View on chart |
| NVCT | ▲ Buy | Open Market | 17,000 | $80K | 12/13/2024 | View on chart |
| NVCT | ▲ Buy | Open Market | 860 | $12K | 7/31/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 2,584 | $36K | 7/28/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 1,556 | $22K | 7/27/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 10,000 | $140K | 7/26/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 2,844 | $42K | 7/21/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 5,394 | $78K | 7/20/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 8,000 | $119K | 7/19/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 9,149 | $136K | 7/18/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 3,285 | $50K | 7/12/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 10,000 | $154K | 7/11/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 8,948 | $136K | 7/7/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 3,179 | $48K | 7/6/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 1,176 | $18K | 7/5/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 16,760 | $276K | 6/26/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 73,175 | $1.3M | 6/23/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 6,999 | $124K | 6/22/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 6,091 | $108K | 6/21/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 12,700 | $225K | 6/16/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 400 | $7K | 6/15/2023 | View on chart |
| NVCT | ▲ Buy | Open Market | 31,724 | $562K | 6/15/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Nuvectis Pharma to speak at Maxim Growth Summit 2026
Nuvectis Pharma announced it will participate in the Maxim Growth Summit 2026. This corporate event provides an opportunity for the company to share updates with investors and analysts. Such appearances are standard for public companies seeking to maintain visibility in the market.
Nuvectis Pharma to speak at Maxim Growth Summit 2026. Nuvectis Pharma announced it will participate in the Maxim Growth Summit 2026. This corporate event provides an opportunity for the company to share updates with investors and analysts. Such appearances are standard for public companies seeking to maintain visibility in the market.